Hypertension is highly prevalent in patients with diabetic nephropathy. Diabetic nephropathy
is the leading cause of CKD and end-stage kidney disease in the United States. The …

Results Fifty subjects with a mean age of 54.5 years were enrolled (25 per group) among
whom 80% were men, 86% diabetic, 62% Hispanic, and 38% African American. The mean …

Background Intradialytic hypertension, a phenomenon where blood pressure increases
during hemodialysis, is associated with increased mortality in hemodialysis patients. The …

Hypertension is prevalent in adult and pediatric end-stage renal disease patients on
hemodialysis. Volume overload is a primary factor contributing to hypertension, and attaining true …

… Author links open overlay panel Peter N. Van Buren MD, MSc 1 , Julia B. Lewis MD 2 ,
Jamie P. Dwyer MD 2 , Tom Greene PhD 3 , John Middleton MD 4 , Mohammed Sika PhD 2 , …

Visit-to-visit blood pressure variability (BPV) is associated with cardiovascular events in the
general population. Data are scarce in chronic kidney disease. We hypothesized that BPV …

Results Mean follow-up serum potassium was 5.0 mEq/L for spironolactone, 4.7 mEq/L for
losartan (P= 0.05 versus spironolactone), and 4.5 mEq/L for placebo (P< 0.001 versus …

Diabetic kidney disease is one of the potential microvascular complications that can occur in
diabetic patients. It is the leading cause of end-stage renal disease (ESRD) in the United …

Intradialytic hypertension is associated with increased morbidity and mortality, impaired
endothelial cell function, and higher overall blood pressure burden. Further investigation is …

The Systolic Blood Pressure Intervention Trial (SPRINT) will compare treatment to a systolic
blood pressure goal of <120 mm Hg to treatment to the currently recommended goal of <140 …